BD Medical Announces New Appointment: Former Johnson & Johnson, Pfizer Executive Joins

Global medical technology giant BD (Becton, Dickinson and Company) recently announced the appointment of Shawn Bevec as Senior Vice President of Investor Relations, effective January 20, 2025.

Source: BD Medical official website

Bevec will be responsible for communicating BD's strategic progress to investors and the financial community, including the initiatives the company is undertaking to enhance shareholder value. He will report to Vito Rook, the interim CFO, pending the formal appointment of a Chief Financial Officer.

Shawn Bevec

"As BD embarks on an exciting new phase of growth, Shawn’s role will be critical in articulating the company’s strategy, performance, and growth opportunities to the investment community, further solidifying BD’s leadership in medical technology," said Vito Rook, BD interim chief financial officer. "His deep experience in investor relations, equity research, and the healthcare sector will be instrumental in advancing our long-term growth plans and creating greater value for patients, customers, and shareholders."

Bevec has extensive experience in investor relations and equity research. Previously, he served as Vice President of Investor Relations at Quest Diagnostics, where he was responsible for investor communications, earnings releases, and related capital market activities. Earlier in his career, he worked as a sell-side research analyst at Deutsche Bank and Susquehanna International Group, focusing on the healthcare services and medical device sectors. Bevec began his career in research and development at Pfizer and Johnson & Johnson, establishing a strong scientific and operational foundation.

Shawn Bevec Resume

Bevec holds a Bachelor of Science in Chemistry from the University of Arizona and a Master of Business Administration from New York University Leonard N. Stern School of Business.

About BD:

BD is one of the largest global pure-play medical technology companies in the world, dedicated to "advancing the world of health by improving medical discovery, diagnostics and the delivery of care." The company focuses on developing transformative technologies, services, and solutions to optimize clinical operations, improve patient care, and fully support frontline healthcare professionals. With over 70,000 employees worldwide, BD delivers billions of products annually, actively promoting global healthcare development. By working closely with customers, BD helps improve treatment outcomes, control costs, enhance clinical efficiency, ensure medical safety, and expand access to healthcare services.